168 related articles for article (PubMed ID: 10487576)
21. Sequential radioimmunotherapy with 177Lu- and 211At-labeled monoclonal antibody BR96 in a syngeneic rat colon carcinoma model.
Eriksson SE; Elgström E; Bäck T; Ohlsson T; Jensen H; Nilsson R; Lindegren S; Tennvall J
Cancer Biother Radiopharm; 2014 Aug; 29(6):238-46. PubMed ID: 24971673
[TBL] [Abstract][Full Text] [Related]
22. 211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation.
Larsen RH; Murud KM; Akabani G; Hoff P; Bruland OS; Zalutsky MR
J Nucl Med; 1999 Jul; 40(7):1197-203. PubMed ID: 10405142
[TBL] [Abstract][Full Text] [Related]
23. Comparative tissue distribution in mice of the alpha-emitter 211At and 131I as labels of a monoclonal antibody and F(ab')2 fragment.
Garg PK; Harrison CL; Zalutsky MR
Cancer Res; 1990 Jun; 50(12):3514-20. PubMed ID: 2340501
[TBL] [Abstract][Full Text] [Related]
24. Improved therapeutic efficacy of a monoclonal antibody radioiodinated using N-succinimidyl-3-(tri-n-butylstannyl)benzoate.
Schuster JM; Garg PK; Bigner DD; Zalutsky MR
Cancer Res; 1991 Aug; 51(16):4164-9. PubMed ID: 1714341
[TBL] [Abstract][Full Text] [Related]
25. Chimeric anti-tenascin antibody 81C6: increased tumor localization compared with its murine parent.
Zalutsky MR; Archer GE; Garg PK; Batra SK; Bigner DD
Nucl Med Biol; 1996 May; 23(4):449-58. PubMed ID: 8832699
[TBL] [Abstract][Full Text] [Related]
26. Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6.
Lee Y; Bullard DE; Humphrey PA; Colapinto EV; Friedman HS; Zalutsky MR; Coleman RE; Bigner DD
Cancer Res; 1988 May; 48(10):2904-10. PubMed ID: 2452014
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional Response in Mouse Thyroid Tissue after 211At Administration: Effects of Absorbed Dose, Initial Dose-Rate and Time after Administration.
Rudqvist N; Spetz J; Schüler E; Parris TZ; Langen B; Helou K; Forssell-Aronsson E
PLoS One; 2015; 10(7):e0131686. PubMed ID: 26177204
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the therapeutic efficacy of 211At- and 131I-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian cancer.
Andersson H; Palm S; Lindegren S; Bäck T; Jacobsson L; Leser G; Horvath G
Anticancer Res; 2001; 21(1A):409-12. PubMed ID: 11299770
[TBL] [Abstract][Full Text] [Related]
29. Applications of 211At and 223Ra in targeted alpha-particle radiotherapy.
Vaidyanathan G; Zalutsky MR
Curr Radiopharm; 2011 Oct; 4(4):283-94. PubMed ID: 22202151
[TBL] [Abstract][Full Text] [Related]
30. N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with alpha-particle emitting 211At.
Vaidyanathan G; Affleck DJ; Bigner DD; Zalutsky MR
Nucl Med Biol; 2003 May; 30(4):351-9. PubMed ID: 12767391
[TBL] [Abstract][Full Text] [Related]
31. Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma.
Batra V; Samanta M; Makvandi M; Groff D; Martorano P; Elias J; Ranieri P; Tsang M; Hou C; Li Y; Pawel B; Martinez D; Vaidyanathan G; Carlin S; Pryma DA; Maris JM
Clin Cancer Res; 2022 Sep; 28(18):4146-4157. PubMed ID: 35861867
[TBL] [Abstract][Full Text] [Related]
32. [Histopathological study of subcutaneous heterograft of human gastric cancer in nude mice treated with 211At labelled monoclonal antibody].
Luo DY
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):23-5. PubMed ID: 8334936
[TBL] [Abstract][Full Text] [Related]
33. The curative and palliative potential of the monoclonal antibody MOv18 labelled with 211At in nude mice with intraperitoneally growing ovarian cancer xenografts--a long-term study.
Andersson H; Lindegren S; Bäck T; Jacobsson L; Leser G; Horvath G
Acta Oncol; 2000; 39(6):741-5. PubMed ID: 11130014
[TBL] [Abstract][Full Text] [Related]
34. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
[TBL] [Abstract][Full Text] [Related]
35. Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate (227)Th-rituximab.
Dahle J; Jonasdottir TJ; Heyerdahl H; Nesland JM; Borrebaek J; Hjelmerud AK; Larsen RH
Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):93-102. PubMed ID: 19593562
[TBL] [Abstract][Full Text] [Related]
36. Antitenascin antibody 81C6 armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands.
Yordanov AT; Hens M; Pegram C; Bigner DD; Zalutsky MR
Nucl Med Biol; 2007 Feb; 34(2):173-83. PubMed ID: 17307125
[TBL] [Abstract][Full Text] [Related]
37. Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results.
Brown MT; Coleman RE; Friedman AH; Friedman HS; McLendon RE; Reiman R; Felsberg GJ; Tien RD; Bigner SH; Zalutsky MR; Zhao XG; Wikstrand CJ; Pegram CN; Herndon JE; Vick NA; Paleologos N; Fredericks RK; Schold SC; Bigner DD
Clin Cancer Res; 1996 Jun; 2(6):963-72. PubMed ID: 9816257
[TBL] [Abstract][Full Text] [Related]
38. Preparation and in vivo evaluation of a novel stabilized linker for 211At labeling of protein.
Talanov VS; Garmestani K; Regino CA; Milenic DE; Plascjak PS; Waldmann TA; Brechbiel MW
Nucl Med Biol; 2006 May; 33(4):469-80. PubMed ID: 16720238
[TBL] [Abstract][Full Text] [Related]
39. In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma.
Nestor M; Persson M; van Dongen GA; Jensen HJ; Lundqvist H; Anniko M; Tolmachev V
Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1296-304. PubMed ID: 16028065
[TBL] [Abstract][Full Text] [Related]
40. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
Andersson H; Lindegren S; Back T; Jacobsson L; Leser G; Horvath G
Anticancer Res; 2000; 20(1A):459-62. PubMed ID: 10769696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
